Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Active as of 2022-01-10 |
{
"resourceType" : "Citation",
"id" : "58",
"meta" : {
"versionId" : "24",
"lastUpdated" : "2023-12-06T00:56:00.523Z"
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: Citation</b><a name=\"58\"> </a><a name=\"hc58\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">ResourceCitation "58" Version "24" Updated "2023-12-06 00:56:00+0000" </p></div><p><b>url</b>: <code>https://fevir.net/resources/Citation/58</code></p><p><b>identifier</b>: FEvIR Object Identifier/58</p><p><b>version</b>: 1.0.0-ballot</p><p><b>title</b>: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</p><p><b>status</b>: active</p><p><b>date</b>: 2022-01-10 13:29:15+0000</p><p><b>publisher</b>: HL7 International / Clinical Decision Support</p><p><b>contact</b>: HL7 International / Clinical Decision Support: <a href=\"http://www.hl7.org/Special/committees/dss\">http://www.hl7.org/Special/committees/dss</a></p><p><b>description</b>: This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>FEvIR Platform Use (Details: Citation Classification Type code fevir-platform-use = 'FEvIR Platform Use', stated as 'FEvIR Platform Use')</td><td>FHIR Resource <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html\">Citation Artifact Classifier</a>#fhir-resource)</span></td></tr></table><p><b>jurisdiction</b>: World <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (m49.htm#001)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>author</b>: Brian S. Alper: </p><h3>Summaries</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Style</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td>Computable Publishing <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-citation-summary-style.html\">Citation Summary Style</a>#comppub)</span></td><td>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.</td></tr></table><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style=\"display: none\">*</td><td>derived-from</td><td><a href=\"https://fevir.net/resources/Evidence/55\">https://fevir.net/resources/Evidence/55</a> "Fourteen_day_mortality_remdesivir_vs_placebo_meta_analysis_ACTT_1_Wang_et_al_WHO_SOLIDARITY"</td></tr></table><blockquote><p><b>citedArtifact</b></p><p><b>identifier</b>: FEvIR Object Identifier/55</p><p><b>dateAccessed</b>: 2021-03-13</p><h3>Versions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Value</b></td></tr><tr><td style=\"display: none\">*</td><td>4</td></tr></table><h3>StatusDates</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Activity</b></td><td><b>Actual</b></td><td><b>Period</b></td></tr><tr><td style=\"display: none\">*</td><td>Created <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-cited-artifact-status-type.html\">Cited Artifact Status Type</a>#created)</span></td><td>true</td><td>?? --> 2020-12-17</td></tr></table><h3>Titles</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td></tr><tr><td style=\"display: none\">*</td><td>Primary title <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-title-type.html\">Title Type</a>#primary)</span></td><td>English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (Tags for the Identification of Languages[4.0.1]#en)</span></td><td>14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).</td></tr></table><h3>Abstracts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Language</b></td><td><b>Text</b></td><td><b>Copyright</b></td></tr><tr><td style=\"display: none\">*</td><td>Primary human use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-cited-artifact-abstract-type.html\">Cited Artifact Abstract Type</a>#primary-human-use)</span></td><td>English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.5.0/CodeSystem-v3-ietf3066.html\">Tags for the Identification of Languages</a>#en)</span></td><td>COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis</td><td>https://creativecommons.org/licenses/by-nc-sa/4.0/</td></tr></table><blockquote><p><b>publicationForm</b></p><h3>PublishedIns</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Title</b></td><td><b>Publisher</b></td><td><b>PublisherLocation</b></td></tr><tr><td style=\"display: none\">*</td><td>Database <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-published-in-type.html\">Published In Type</a>#D019991)</span></td><td>Fast Evidence Interoperability Resources (FEvIR) Platform</td><td><span>: Computable Publishing LLC</span></td><td>Ipswich, MA, USA</td></tr></table><p><b>lastRevisionDate</b>: 2020-12-21</p><p><b>language</b>: English <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (Tags for the Identification of Languages[4.0.1]#en)</span></p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p></blockquote><h3>WebLocations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Classifier</b></td><td><b>Url</b></td></tr><tr><td style=\"display: none\">*</td><td>JSON <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-url-classifier.html\">Artifact Url Classifier</a>#json)</span>, Computable resource <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-url-classifier.html\">Artifact Url Classifier</a>#computable-resource)</span></td><td><a href=\"Evidence-55.html\">14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)</a></td></tr></table><blockquote><p><b>classification</b></p><p><b>type</b>: Knowledge Artifact Type <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-cited-artifact-classification-type.html\">Cited Artifact Classification Type</a>#knowledge-artifact-type)</span></p><p><b>classifier</b>: FHIR Resource <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html\">Citation Artifact Classifier</a>#fhir-resource)</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: FHIR Resource <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-citation-artifact-classifier.html\">Citation Artifact Classifier</a>#fhir-resource)</span></p><p><b>classifier</b>: Evidence <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-fhir-types.html\">All FHIR Types</a>#Evidence)</span></p></blockquote><blockquote><p><b>classification</b></p><p><b>type</b>: keyword major topic <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span></p><p><b>classifier</b>: remdesivir <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span>, COVID-19 <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span>, pharmaceutical treatment <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-179423.html\">Evidence Based Medicine on FHIR Implementation Guide Code System</a>#defined-in-text "Defined in text")</span></p></blockquote><blockquote><p><b>contributorship</b></p><p><b>complete</b>: true</p><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name=\"hccontributor0\"> </a></p><blockquote><p/><p><a name=\"contributor0\"> </a></p><p><a name=\"hccontributor0\"> </a></p><p><b>identifier</b>: <code>https://orcid.org/</code>/0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href=\"mailto:balper@computablepublishing.com\">balper@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: BS</p><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Conceptualization <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html\">Artifact Contribution Type</a>#conceptualization)</span>, Data curation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html\">Artifact Contribution Type</a>#data-curation)</span>, Supervision <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html\">Artifact Contribution Type</a>#supervision)</span></p><p><b>role</b>: Author/Creator <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-contributor-role.html\">Contributor Role</a>#author)</span></p><p><b>correspondingContact</b>: true</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name=\"hccontributor1\"> </a></p><blockquote><p/><p><a name=\"contributor1\"> </a></p><p><a name=\"hccontributor1\"> </a></p><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href=\"mailto:jdehnbostel@computablepublishing.com\">jdehnbostel@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: J</p><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Formal analysis <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html\">Artifact Contribution Type</a>#formal-analysis)</span>, Data curation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html\">Artifact Contribution Type</a>#data-curation)</span></p><p><b>role</b>: Author/Creator <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-contributor-role.html\">Contributor Role</a>#author)</span></p><p><b>correspondingContact</b>: false</p></blockquote><blockquote><p><b>entry</b></p><p><b>contributor</b>: <a name=\"hccontributor2\"> </a></p><blockquote><p/><p><a name=\"contributor2\"> </a></p><p><a name=\"hccontributor2\"> </a></p><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href=\"mailto:kshahin@computablepublishing.com\">kshahin@computablepublishing.com</a></p></blockquote><p><b>forenameInitials</b>: K</p><p><b>affiliation</b>: <span>: Computable Publishing LLC</span></p><p><b>contributionType</b>: Software <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-artifact-contribution-type.html\">Artifact Contribution Type</a>#software)</span></p><p><b>role</b>: Author/Creator <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://hl7.org/fhir/R5/codesystem-contributor-role.html\">Contributor Role</a>#author)</span></p><p><b>correspondingContact</b>: false</p></blockquote></blockquote></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor0</b><a name=\"contributor0\"> </a><a name=\"hccontributor0\"> </a></p><p><b>identifier</b>: <code>https://orcid.org/</code>/0000-0003-4300-4928</p><p><b>name</b>: Brian S. Alper </p><p><b>telecom</b>: <a href=\"mailto:balper@computablepublishing.com\">balper@computablepublishing.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor1</b><a name=\"contributor1\"> </a><a name=\"hccontributor1\"> </a></p><p><b>name</b>: Joanne Dehnbostel </p><p><b>telecom</b>: <a href=\"mailto:jdehnbostel@computablepublishing.com\">jdehnbostel@computablepublishing.com</a></p></blockquote><hr/><blockquote><p><b>Generated Narrative: Practitioner #contributor2</b><a name=\"contributor2\"> </a><a name=\"hccontributor2\"> </a></p><p><b>name</b>: Khalid Shahin </p><p><b>telecom</b>: <a href=\"mailto:kshahin@computablepublishing.com\">kshahin@computablepublishing.com</a></p></blockquote></div>"
},
"contained" : [
{
"resourceType" : "Practitioner",
"id" : "contributor0",
"identifier" : [
{
"system" : "https://orcid.org/",
"value" : "0000-0003-4300-4928",
"assigner" : {
"display" : "ORCID"
}
}
],
"name" : [
{
"family" : "Alper",
"given" : [
"Brian S."
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "balper@computablepublishing.com"
}
]
},
{
"resourceType" : "Practitioner",
"id" : "contributor1",
"name" : [
{
"family" : "Dehnbostel",
"given" : [
"Joanne"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "jdehnbostel@computablepublishing.com"
}
]
},
{
"resourceType" : "Practitioner",
"id" : "contributor2",
"name" : [
{
"family" : "Shahin",
"given" : [
"Khalid"
]
}
],
"telecom" : [
{
"system" : "email",
"value" : "kshahin@computablepublishing.com"
}
]
}
],
"url" : "https://fevir.net/resources/Citation/58",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "58",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"version" : "1.0.0-ballot",
"title" : "Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)",
"status" : "active",
"date" : "2022-01-10T13:29:15.764Z",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description" : "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.",
"useContext" : [
{
"code" : {
"system" : "http://hl7.org/fhir/citation-classification-type",
"code" : "fevir-platform-use",
"display" : "FEvIR Platform Use"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-artifact-classifier",
"code" : "fhir-resource",
"display" : "FHIR Resource"
}
]
}
}
],
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"author" : [
{
"name" : "Brian S. Alper"
}
],
"summary" : [
{
"style" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-summary-style",
"code" : "comppub",
"display" : "Computable Publishing"
}
]
},
"text" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55."
}
],
"relatedArtifact" : [
{
"type" : "derived-from",
"resourceReference" : {
🔗 "reference" : "https://fevir.net/resources/Evidence/55",
"type" : "Evidence"
}
}
],
"citedArtifact" : {
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "55",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"dateAccessed" : "2021-03-13",
"version" : {
"value" : "4"
},
"statusDate" : [
{
"activity" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/cited-artifact-status-type",
"code" : "created",
"display" : "Created"
}
]
},
"actual" : true,
"period" : {
"end" : "2020-12-17"
}
}
],
"title" : [
{
"type" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/title-type",
"code" : "primary",
"display" : "Primary title"
}
]
}
],
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"version" : "4.0.1",
"code" : "en",
"display" : "English"
}
]
},
"text" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)."
}
],
"abstract" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/cited-artifact-abstract-type",
"code" : "primary-human-use",
"display" : "Primary human use"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "en",
"display" : "English"
}
]
},
"text" : "COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis",
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
}
],
"publicationForm" : [
{
"publishedIn" : {
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/published-in-type",
"code" : "D019991",
"display" : "Database"
}
]
},
"title" : "Fast Evidence Interoperability Resources (FEvIR) Platform",
"publisher" : {
"type" : "Organization",
"display" : "Computable Publishing LLC"
},
"publisherLocation" : "Ipswich, MA, USA"
},
"lastRevisionDate" : "2020-12-21",
"language" : [
{
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"version" : "4.0.1",
"code" : "en",
"display" : "English"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/"
}
],
"webLocation" : [
{
"classifier" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-url-classifier",
"code" : "json",
"display" : "JSON"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-url-classifier",
"code" : "computable-resource",
"display" : "Computable resource"
}
]
}
],
"url" : "https://fevir.net/resources/Evidence/55"
}
],
"classification" : [
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/cited-artifact-classification-type",
"code" : "knowledge-artifact-type",
"display" : "Knowledge Artifact Type"
}
]
},
"classifier" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-artifact-classifier",
"code" : "fhir-resource",
"display" : "FHIR Resource"
}
]
}
]
},
{
"type" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/citation-artifact-classifier",
"code" : "fhir-resource",
"display" : "FHIR Resource"
}
]
},
"classifier" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/fhir-types",
"code" : "Evidence",
"display" : "Evidence"
}
]
}
]
},
{
"type" : {
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "keyword major topic"
},
"classifier" : [
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "remdesivir"
},
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "COVID-19"
},
{
"coding" : [
{
"system" : "https://fevir.net/resources/CodeSystem/179423",
"code" : "defined-in-text",
"display" : "Defined in text"
}
],
"text" : "pharmaceutical treatment"
}
]
}
],
"contributorship" : {
"complete" : true,
"entry" : [
{
"contributor" : {
"reference" : "#contributor0",
"type" : "Practitioner"
},
"forenameInitials" : "BS",
"affiliation" : [
{
"display" : "Computable Publishing LLC"
}
],
"contributionType" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "conceptualization",
"display" : "Conceptualization"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "data-curation",
"display" : "Data curation"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "supervision",
"display" : "Supervision"
}
]
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/contributor-role",
"code" : "author",
"display" : "Author/Creator"
}
]
},
"correspondingContact" : true
},
{
"contributor" : {
"reference" : "#contributor1",
"type" : "Practitioner"
},
"forenameInitials" : "J",
"affiliation" : [
{
"display" : "Computable Publishing LLC"
}
],
"contributionType" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "formal-analysis",
"display" : "Formal analysis"
}
]
},
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "data-curation",
"display" : "Data curation"
}
]
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/contributor-role",
"code" : "author",
"display" : "Author/Creator"
}
]
},
"correspondingContact" : false
},
{
"contributor" : {
"reference" : "#contributor2",
"type" : "Practitioner"
},
"forenameInitials" : "K",
"affiliation" : [
{
"display" : "Computable Publishing LLC"
}
],
"contributionType" : [
{
"coding" : [
{
"system" : "http://hl7.org/fhir/artifact-contribution-type",
"code" : "software",
"display" : "Software"
}
]
}
],
"role" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/contributor-role",
"code" : "author",
"display" : "Author/Creator"
}
]
},
"correspondingContact" : false
}
]
}
}
}
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2024-05-16
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change